LXR MODULATORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES

Details for Australian Patent Application No. 2003223684 (hide)

Owner CHUGAI SEIYAKU KABUSHIKI KAISHA

Inventors ARRHENIUS, Thomas; CHENG, JieFei; NADZAN, Alex, M.

Pub. Number AU-A-2003223684

PCT Number PCT/US03/12391

PCT Pub. Number WO2003/090732

Priority 60/374,650 23.04.02 US

Filing date 21 April 2003

Wipo publication date 10 November 2003

International Classifications

A61K 031/12 - Ketones

A61K 031/17 - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 031/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 031/42 - Oxazoles

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

A61P 009/10 Drugs for disorders of the cardiovascular system

A61K 031/16 - Amides, e.g. hydroxamic acids

A61K 031/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/374,650 23.04.02 US

18 December 2003 Application Open to Public Inspection

  Published as AU-A-2003223684

13 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003223685-Measurement system including a sensor mounted in a contact lens

2003223683-PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR EXPRESSION LEVEL AS AN INDEX OF ORGAN DAMAGE AND REGENERATION